Skip to main content

Advertisement

Table 1 Top miRNAs regulated by the PI3K inhibitor LY294002

From: miR-19b enhances proliferation and apoptosis resistance via the EGFR signaling pathway by targeting PP2A and BIM in non-small cell lung cancer

Rank miRNAs Fold change (log2)1 adjusted p-value
1 hsa-miR-100-5p −2.30 2.15E-38
2 hsa-miR-125b-5p −2.23 3.40E-36
3 hsa-miR-205-5p −1.67 5.63E-21
4 hsa-miR-19a-3p2 −1.59 2.28E-14
5 hsa-miR-18a-5p2 −1.57 2.28E-14
6 hsa-miR-181a-5p 1.56 8.78E-13
7 hsa-miR-503-5p −1.44 7.17E-11
8 hsa-miR-19b-3p2 −1.43 1.50E-14
9 hsa-miR-196b-5p −1.25 6.66E-07
10 hsa-let-7b-5p −1.14 1.73E-09
11 hsa-miR-372-3p −1.12 1.25E-01
12 hsa-miR-9-5p −1.05 3.65E-08
13 hsa-miR-20a-5p + hsa-miR-20b-5p2 −1.04 3.65E-08
14 hsa-miR-422a −1.02 1.38E-05
15 hsa-miR-1180-3p −1.02 6.77E-07
16 hsa-miR-374a-5p −1.02 1.48E-07
17 hsa-miR-99b-5p −1.01 3.42E-06
  1. 1Fold change relative to DMSO treated cells. Cut off was set to ±0.4 log2FC (n = 3)
  2. 2OncomiR-1 cluster